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Word count Mini-abstract: 49 1 
Low bone mineral density (BMD) gives an increased risk of fractures, which can lead to premature death. Can 2 
BMD of the wrist predict mortality? BMD consistent with osteopenia and osteoporosis gave a significantly 3 
increased risk of death for both men and women in a general population in Tromsø, Norway. 4 
 5 
Word count abstract: 249 6 
Purpose 7 
To investigate if bone mineral density (BMD) levels of the distal forearm, consistent with osteopenia and 8 
osteoporosis, can predict mortality and if grip strength is an effect modifier. 9 
Methods 10 
The study population constituted 6 565 participants aged 50-79 years at baseline in the Tromsø study wave 4 11 
conducted in 1994-5. Forearm BMD measured by SXA was categorized as “normal”, “osteopenia” or 12 
“osteoporosis” following WHO’s definition. Cox regression with all-cause mortality as the outcome over 22 13 
years of follow-up was performed for men and women separately, adjusting for health-related factors, as well as 14 
BMD by grip strength interaction. A secondary analysis with 15 years follow-up also adjusted for hip fractures 15 
and osteoporotic fractures. 16 
Results 17 
During follow-up, 3 176 of participants died (47%). Those categorized as osteoporotic had higher mortality 18 
hazard ratio (HR) compared to those with normal BMD; Men HR=1.37 (95% confidence interval (CI) 1.19, 19 
1.58) and women HR=1.32 (1.14, 1.53), adjusted for age, body mass index, physical activity, smoking habits, 20 
education, health status, chronic diseases and grip strength. Corresponding HRs for osteopenia were; Men 21 
HR=1.13 (1.00, 1.27) and women HR=1.17 (1.01, 1.35). Further adjustments for fractures did only marginally 22 
attenuate the results, and HRs were still significant. There was no grip strength by BMD interaction.  23 
Conclusion 24 
Men and women with low distal forearm BMD-values, consistent with osteoporosis or osteopenia, had an 25 
increased mortality compared to normal BMD participants. High grip strength did not modify this association, 26 
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 31 
 32 
Word count article: 3 579 33 
Introduction 34 
Osteoporosis constitutes an important public health concern with its high incidence in Western populations, and 35 
progressive prevalence in Asia [1, 2]. Osteoporosis is known to vary by gender and age [3]. It is often defined as 36 
a disease of women because the prevalence and fracture rates are much higher among females, but once an 37 
osteoporotic hip fracture has occurred, excess mortality has been found to be higher in men [3, 4]. The incidence 38 
of osteoporosis is increasing with age, occurring mainly above the age of 50 years [5].  39 
 40 
Osteopenia is the precursor of osteoporosis. The World Health Organization (WHO) Study Group on 41 
Osteoporosis has defined osteopenia and osteoporosis as bone mineral density (BMD) of more than 1 and 2.5 42 
standard deviations (SDs), respectively, below the mean BMD of the young, white, female adult reference 43 
population [6]. Based on data from the United States, it has been estimated that 30 percent or more of all 44 
postmenopausal, white women have osteoporosis [7]. The lifetime risk of any fracture of the hip, spine, 45 
proximal- or distal forearm, all considered typical osteoporotic fractures, was estimated to be 46 percent in 46 
women and 22 percent in men from age 50 years onward in a Swedish population [8]. As life expectancy 47 
increases, the population burden of osteoporosis and related fragility fractures will increase [1, 9].   48 
 49 
 50 
A systematic review and meta-analysis from 2013 [10] found an inverse relationship between BMD and all-51 
cause mortality. The same result was found for women with type 2 diabetes [11]. An important pathway linking 52 
low BMD to mortality is via fractures, and hip fractures in particular. Furthermore, the association between 53 
BMD and mortality could be confounded by physical fitness, physical activity, body mass, smoking habits, level 54 




Grip strength measurements have been recommended in order to identify old people with sarcopenia [19] (low 57 
muscle mass and low muscle function). Low grip strength has also been found to predict disability, impaired 58 
quality of life, falls and mortality [20-22], while high grip strength may indicate resilience to aging [23]. 59 
 60 
Osteoporotic fractures of the proximal femur are particularly associated with excess mortality and studies have 61 
consistently found that this association increases with age [4, 24]. For distal forearm fractures however, excess 62 
mortality is found to be lower or non-significant [24], but a prior wrist fracture can increase the risk of any 63 
osteoporotic fracture later in life [25, 26]. Recent studies have found that osteoporosis is more easily detected in 64 
the peripheral regions (wrist) than in the central regions (spine and hip) [27] and wrist BMD has better accuracy 65 
than lumbar BMD in diagnosing osteoporosis in postmenopausal women [28]. Measuring BMD in the distal 66 
forearm might reveal a BMD deficiency at an earlier stage and give better prerequisites for treatment and 67 
fracture prevention. 68 
 69 
The main aim of this paper was to assess the predictive value of established definitions for osteopenia and 70 
osteoporosis in evaluating risk of mortality. Identifying individuals at high risk is crucial in order to provide 71 
interventions on amendable risk factors for osteopenia or osteoporosis. There have been previous studies on how 72 
mortality is affected by different treatments of osteoporosis, fracture types [4, 24, 29] and BMD values in 73 
various populations [10, 11, 30]. However, the association between osteoporosis and osteopenia of the distal 74 
forearm and mortality, and the possible mediating effect of grip strength has to the very best of our knowledge 75 
not been examined in a population-based study before. Thus an additional aim of this paper was to investigate if 76 
a strong grip modified the potential association between low BMD and mortality and whether the association 77 
was confounded by BMI, smoking, physical activity level, self-reported health status, level of education or 78 
chronic diseases such as angina, stroke, myocardial infarction, diabetes and asthma. We hypothesized that those 79 
with distal forearm BMD categorized as osteoporotic or osteopenic had a higher mortality risk compared to those 80 
with normal BMD-values, but that this increased risk could be partly counteracted by a high grip strength.  81 
 82 
Method 83 
Study population 84 
The Tromsø Study was initiated in 1974 and is a longitudinal, population based, multi-purpose study focusing on 85 
lifestyle-related diseases [31]. There have been seven study waves, and our study population is comprised of 86 
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participants from the fourth wave, conducted in 1994-95. This wave included a bone densitometry measurement 87 
as a part of additional testing that was offered to all participants aged 55-74 years, all women aged 50-55 years 88 
and a random selection of 10-15 percent of participants aged 24-55 years and 74-85 years. In the current 89 
analyses, only participants aged 50-79 years were included. The attendance rate was 76 percent among men and 90 
79 percent among women in this age group. Our study population consisted of 6 565 participants, 3 818 women 91 
with a mean age of 60.7 years (SD=7.4) and 2 747 men with a mean age of 62.6 years (SD=6.4).  92 
 93 
Assessment of bone mineral density (BMD) 94 
Bone densitometry using SXA was performed on the non-dominant forearm at distal and ultra-distal sites with 95 
two single x-ray absorptiometry devices (DTX-100; Osteometer MediTech, Inc., Hawthorne, California). Further 96 
specification of the testing procedure can be found elsewhere [32]. No significant difference has been detected 97 
regarding precision of the distal and ultra-distal measurement [33]. The distal measurement was chosen for our 98 
analyses, including both radius and ulna. Osteopenia and osteoporosis were defined respectively as 1 and 2.5 99 
SDs below the mean of young, healthy men and women (see below).  100 
 101 
Reference values 102 
Gender specific internal BMD reference values were created for osteopenia and osteoporosis, based on BMD 103 
values corresponding to 1 and 2.5 standard deviations below the mean BMD of healthy men and women aged 104 
24-39 years in the Tromsø 4 densitometry data. Besides gender and age range, the reference populations were 105 
defined by a dichotomous variable, “healthy” (Yes/no), which was based on the following disease-related 106 
questions: Do you have, or have you had a myocardial infarction? (Yes/no); Do you have, or have you had 107 
angina pectoris? (Yes/no); Do you have, or have you had a cerebral stroke/brain hemorrhage? (Yes/no); Do you 108 
have, or have you had asthma? (Yes/no); Do you have, or have you had diabetes? (Yes/no); What is your current 109 
state of health? (Poor/not so good/good/very good). Those who reported “good” or “very good” self-rated health 110 
combined with “no” on all the disease related questions were defined as “healthy”, and this group was used when 111 
calculating reference values for categorization into “normal BMD”, “osteopenia” and “osteoporosis”. Only 112 
including the “healthy” participants resulted in 252 women with a mean BMD-value of 0.471 g/cm2 (SD=0.043) 113 
and 147 men with a mean BMD-value of 0.575 g/cm2 (SD=0.045). Thus, 2.5 SD below mean BMD 114 
(osteoporosis) corresponded to 0.364 g/cm2 in women and 0.464 g/cm2 in men, and 1.0 SD below mean 115 




Ascertainment of deaths 118 
The outcome in this study was all-cause mortality. Data on each participant was linked, by the means of the 119 
unique personal identification number, to the Norwegian Cause of Death Registry for assessment of death, and to 120 
the National Registry for assessment of emigration. Participants were followed from baseline survey in 1994-95 121 
until emigration, death or November 5th, 2016, whichever occurred first.  122 
 123 
Covariates 124 
Covariates known to be associated with lower BMD and mortality were selected a priori for inclusion as possible 125 
confounders in addition to age and gender. Height and weight was measured by trained personnel in The Tromsø 126 
Study and body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared 127 
(kg/m2) and grouped as: low = BMI ≤20.00 kg/m2, normal =20.01 kg/m2 to 25.00, overweight = 25.01 to 30.00 128 
kg/m2 and obese > 30.00 kg/m2. Smoking was self-reported, and categorized in three groups as current, previous, 129 
or never-smoker. Education level was based on years of completed education grouped into five levels ranging 130 
from “7-10 years primary/secondary school” to “college/university 4 or more years”. Level of physical activity 131 
was self-reported by counting hours of light physical activity (not sweating or out of breath) and hard physical 132 
activity (sweating and/or out of breath) during a typical week in the previous year. The number of hours per 133 
week for each variable was categorized in four groups: none, less than one, one to two, three or more. Chronic 134 
diseases were self-reported in Tromsø 4 with alternatives “yes” or “no” following questions about stroke, 135 
myocardial infarction, angina, diabetes or asthma in their medical history along with questions regarding self-136 
perceived health categorized as: very good, good, not so good, and poor. Grip strength of the non-dominant hand 137 
was measured in bar using a Martin vigorimeter. Each participant was allowed two attempts, and the highest 138 
score was recorded and used in analyses. Grip strength was grouped into gender specific quartiles. Records for 139 
fractures were available for all participants until February 22th 2010. Fractures of the femur neck and –140 
trochanter were defined as “hip fractures”. These in addition to distal fractures of ulna and radius were defined as 141 
“osteoporotic fractures”. Vertebral fractures were not reported in the material. 142 
 143 
Statistics 144 
Separate analyses were conducted for men and women. A Cox proportional hazards survival model was used to 145 
assess the associations between T-score groups based on distal forearm BMD and mortality. We successively 146 
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adjusted for health- and lifestyle-related variables in three models; model 1: (attained) age, model 2: model 1 + 147 
BMI, level of physical activity, smoking habits and category of completed education, model 3: model 2 + self-148 
reported health status and self-reports of chronic diseases including asthma, diabetes, angina pectoris, stroke and 149 
myocardial infarction. In addition, grip strength by BMD interaction was tested in a fourth model. Fractures were 150 
included in a secondary analysis since fracture data was only available until February 22th 2010, giving a shorter 151 
follow-up period. Model 1 is minimally adjusted for age (attained), without fracture variables. Model 2 and 4 152 
minimally adjusted for age (attained) and hip fractures or osteoporotic fractures. Model 3 and 5 fully adjusted in 153 
addition to hip fractures or osteoporotic fractures. The fracture variables were modelled as time-dependent 154 
covariates in order to avoid immortal time-bias. The proportional hazard (PH) assumption was inspected visually 155 
and by formal tests based on scaled Schoenfeld residuals. Statistical significance was determined by an alpha 156 
level of 0.05. The statistical analysis was carried out with Stata/SE 15.  157 
 158 
Results 159 
During follow up in the main analysis, 3 176 (46.8%) of the 6 790 participants died, 1 538 women and 1 638 160 
men. Fifty-four participants were censored due to emigration. The mean BMD-value of the total study 161 
population 50 to 79 years was 0.458 g/cm2 (SD=0.094), 0.403 g/cm2 (SD 0.069) in women and 0.533 g/cm2 (SD 162 
0.067) in men (Table 1). According to the definition, 1 512 (38%) female participants had normal BMD, 1 329 163 
(34%) had osteopenia and 1 104 (28%) had osteoporosis. Corresponding numbers in men were 1 575 (55%), 870 164 
(31%) and 400 (14%) (Table 1 and 2).  165 
 166 
In our secondary analysis including fracture data, 1 242 women and 434 men experienced a fracture during 15 167 
years follow-up from baseline to February 22th 2010. Among women, 265 experienced a hip fracture and 479 168 
experienced a distal forearm fracture. Corresponding numbers among men were 132 and 194. 169 
 170 
Participants categorized as having osteoporosis were significantly older, had a lower BMI, lower grip strength, 171 
performed less hard physical activity, had inferior self-reported health and a higher percentage had experienced a 172 
stroke compared to those with normal BMD-values (Table 2). Among women, the osteoporosis group also 173 
performed less light physical activity, they were lower educated and had a higher lifetime prevalence of angina 174 
pectoris or a myocardial infarction than participants with normal BMD. Significantly more men were smokers in 175 




Cox regression revealed a significantly higher mortality in both women and men with osteoporosis and 178 
osteopenia compared to the normal BMD groups (Table 3). In the fully adjusted model, including adjustments 179 
for age, BMI, level of education, physical activity, smoking, self-reported health, chronic diseases and grip 180 
strength, the hazard ratio (HR) was 1.32 (95 % confidence interval (CI) 1.14 to 1.53) for women and 1.37 (95% 181 
CI 1.19 to 1.58) for men with osteoporosis compared to those with normal BMD. Corresponding HRs for 182 
mortality in participants with osteopenia were 1.17 (95% CI 1.01 to 1.35) in women and 1.13 (95% CI 1.00 to 183 
1.27) in men. There was no grip strength by BMD interaction in women (p=0.84) or in men (p=0.55), see Figure 184 
1 and 2 illustrating the effect of “low” (lowest quartile) and “high” (three highest quartiles) grip strength on the 185 
association between BMD as a continuous variable and HR for mortality. Tests of the proportional hazards 186 
assumption using scaled Schoenfeld residuals indicated some violation of proportionality of hazard. For 187 
osteoporosis the HRs were comparable in the three time periods 1994-2000, 2001-2006, 2007-2016 in both 188 
genders. For osteopenia, however, the HRs were slightly lower in the first time periods in men, while in women 189 
they were comparable. Despite this slight violation of PH, results are presented as an average for the whole 190 
period.  191 
In the secondary analysis, adjusting for hip fractures or osteoporotic fractures did not explain the increased 192 
mortality among participants with osteoporosis. The association between osteopenia and mortality was still 193 
significant in women after adjusting for fractures, but not in men (Table 4). 194 
 195 
Discussion 196 
To the best of our knowledge, this is the first population-based study to examine the association between 197 
osteoporosis and osteopenia of the distal forearm and mortality, and the possible mediating effect of grip 198 
strength. We found a statistically significant association between osteopenic and osteoporotic BMD-levels of the 199 
distal forearm and increased mortality rate in both women and men.  200 
 201 
The strengths of the present study include the population-based design, standardized objective measures of bone 202 
mineral density and grip strength, a large sample size and a long follow-up of 22 years with updated time of 203 
death from as recently as November 2016. The population consists of people living in both rural and urban areas 204 




However, the study is not without limitations. Self-reported variables challenge the internal validity of any study 207 
[34, 35]. State of health, presence of chronic diseases, level of physical activity, education and smoking habits 208 
are self-reported variables and might be subject to over- or under-estimation due to recall bias [36] or socially 209 
desirable responding (SDR) [37]. This can in turn lead to an under-estimation of the potential association 210 
between variables. Though this could be the case with some of the variables mentioned above, the outcome in 211 
the current analysis was the registry-based hard endpoint of deaths while our main exposure variables (BMD and 212 
grip strength) were measured objectively.   213 
 214 
We controlled for variables that were measured at baseline in 1994/5. During the follow-up of 22 years, it is 215 
likely that some variables changed, especially the presence of chronic diseases since it is well known that 216 
comorbidity increases in older age. The participants may also have experienced significant changes in BMD 217 
during follow-up that could be associated with excess mortality. This could be subject for further research. 218 
 219 
We created our own reference values in order to define osteopenia and osteoporosis for our population, but the 220 
association between BMD as a continuous variable and mortality was also analyzed, allowing the reader to study 221 
the whole spectrum of BMD independent of our categorization into osteoporosis, osteopenia and normal BMD. 222 
Modern methods for BMD-testing has changed over the past 22 years and we were unsuccessful in retrieving 223 
external reference-values for SXA of the distal forearm. There are both strengths and limitations in creating our 224 
own reference values. We have no guarantee that our reference groups are similar to those used in other studies 225 
and the variation within the reference group warrants the size of 1 SD which in turn make out the cut-off values. 226 
However, this resulted in 28 percent of the women being categorized as osteoporotic and this is comparable to 227 
other findings in Caucasian women [7], considering that the oldest old were not included in this study. A 228 
strength of creating a reference group from the same study is that they share the same geographical and cultural 229 
affiliation, we know how the BMD has been measured and tests are performed by the same professionals, 230 
following the same protocols as in the main analyses.  231 
Dementia and other cognitive impairments increase the risk of mortality. 6.1 % of all deaths in Norway in 2016 232 
were registered with dementia as the underlying cause of death [38]. Cognitive assessments were not 233 
incorporated in Tromsø 4 so we could not control for cognitive impairments or dementia at baseline in our 234 
analysis, however, later study waves including the same population revealed that a low proportion of the 235 
participants had cognitive impairments, with 7.3% scoring low on one or more of the cognitive tests in addition 236 
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to self-report of memory problems. Out of these, only one participant had dementia. It is therefore unlikely that 237 
dementia confounded the association we found between osteoporosis/osteopenia and mortality.  238 
 239 
Our findings indicate that BMD measurements of the distal forearm has a predictive value in mortality risk 240 
assessment and mortality can be predicted using the commonly accepted T-values of -1 and -2.5 for osteopenia 241 
and osteoporosis, though only demonstrated on a group level. In evaluating an individual’s mortality risk, 242 
osteopenia and osteoporosis should be viewed as independent risk factors of death that will add to the total risk 243 
along with other known risk factors.  244 
 245 
The association between mortality and osteoporosis was slightly stronger in men while the association with 246 
osteopenia was somewhat stronger in women, indicating that smaller deficiencies in BMD might be more serious 247 
in women. However, the between-gender differences are not large enough to make such assumptions based on 248 
this material. The association between osteoporosis and increased mortality was still significant in both men and 249 
women after adjusting for fractures, indicating that there might be a more complex relationship between low 250 
BMD and mortality risk than we are currently aware of. Several authors have found an inverse relationship 251 
between BMD and risk of cardiovascular disease and -death [39, 40]. Although we controlled for myocardial 252 
infarction and angina, these variables were measured at baseline and more cases probably occurred during 253 
follow-up, potentially more often among those with low BMD.  254 
 255 
That our main analysis also show significantly higher mortality for osteopenic BMD-values suggests that it 256 
might be valuable to initiate treatment measures already at this stage, though previous research debates the cost-257 
effectiveness of pharmacological treatment of osteopenia purely based on T-scores [41, 42]. Low BMD is mainly 258 
seen as a risk factor of fractures, and it has been debated whether expensive medication is the right way to 259 
prevent fractures as opposed to means of falls prevention [43]. However, one intervention does not exclude the 260 
other, and falls prevention should be emphasized regardless of any medical prescriptions. In Norway, 261 
osteoporosis appears to be both under-diagnosed and under-treated according to Devold et al. [44] who found 262 
that one year after experiencing a hip fracture, only 14.6 percent of women and 4.2 percent of men used some 263 
form of anti-osteoporotic medication. Grey et al. [29] found a significant reduction of mortality risk associated 264 
with use of fracture-preventing medication in their meta-analysis and the effect was largest in older, frailer 265 
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individuals. The decision to prescribe medication should in any case be based on a full assessment of the 266 
person’s fracture risk and potential benefits of treatment.  267 
In our study, a general population was screened for low BMD independent of prior indication of a BMD-268 
deficiency. There are currently no routines for general screening of BMD in Norway, but our findings indicate 269 
that general BMD measurements can be of value in identifying individuals with higher risk of mortality. 270 
Schousboe et al. [45] found that universal BMD-screening of the population combined with alendronate 271 
therapy for those found to have osteoporosis is highly cost‐effective for women aged 65 and older and may 272 
be cost saving for ambulatory women aged 85 and older.  273 
Based on our study, we cannot conclude whether treatment of low BMD will help decrease risk of 274 
mortality or if the BMD deficiency is merely a marker for frailty. In practical terms, measured osteopenia 275 
and osteoporosis in the distal forearm reveals individuals with increased risk of mortality, which warrants 276 
closer follow-up of these individuals by health care personnel.  277 
In a previous analysis from the Tromsø 4 study wave, high grip strength was associated with lower risk of 278 
mortality [20], yet grip strength did not attenuate or modify the higher mortality risk for participants with 279 
osteoporosis or osteopenia in our analyses. Thus, these variables seem to be independently associated with 280 
mortality. 281 
 282 
In elderly people, most wrist fractures occur in individuals with low BMD who are relatively healthy and active 283 
and have good neuromuscular function [46]. BMD is commonly measured after a low-energy trauma fracture. 284 
Even though a wrist fracture in itself has not been found to increase the risk of mortality [24], our findings 285 
indicate that an underlying BMD-deficiency in the forearm can have more serious implications, and measures 286 
should be taken accordingly with respect to current medical guidelines for prevention of fractures and treatment 287 




Women and men with distal forearm BMD-values consistent with both osteoporosis and osteopenia had an 292 
increased all-cause mortality compared to people with normal BMD-values, independent of lifestyle- and health-293 
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Table 1. BMD-values of women and men aged 50-79 years in the Tromsø 4 study, categorized as “normal”, “osteopenia” 















       
Women 3 945 0.403 (0.069) 38.3 33.7 28.0 1538 (39.0) 
50-54 1 050 0.453 (0.050) 70.2 25.3 4.5 135 (12.9) 
55-59 840 0.421 (0.055) 46.1 39.5 14.4 175 (20.8) 
60-64 695 0.393 (0.060) 27.5 41.9 30.7 247 (35.5) 
65-69 752 0.365 (0.064) 16.4 34.7 48.9 475 (63.2) 
70-74 577 0.352 (0.063) 12.0 29.8 58.2 477 (82.7) 
75-79 31 0.341 (0.081) 16.1 22.6 61.3 29 (93.5) 
       
Men 2 845 0.533 (0.067) 55.4 30.6 14.0 1638 (57.6) 
50-54 225 0.564 (0.050) 77.8 20.0 2.2 40 (17.8) 
55-59 793 0.552 (0.056) 67.6 27.1 5.3 258 (32.5) 
60-64 700 0.539 (0.061) 56.1 32.7 11.1 378 (54.0) 
65-69 606 0.520 (0.069) 46.4 33.7 20.0 468 (77.2) 
70-74 494 0.501 (0.073) 36.0 34.4 29.6 467 (94.5) 
75-79 27 0.492 (0.099) 44.4 25.9 29.6 27 (100.0) 





Table 2. Number or proportions (%) of participants in the Tromsø 4-study in groups: “Normal BMD”, “Osteopenia” and 
“Osteoporosis”at baseline in 1994/1995. Number of deaths, person years (py) and mortality rate per 1 000 py during 22 
years follow up. Each variable listed in women and men. 
 N Normal BMD Osteopenia Osteoporosis Trend* 
Women      
Number of participants 3 945 1 512 1 329 1 104  
Number of deaths 1 501 327 498 676 <0.001 
Person years (py) 3 945 30 032 24 572 18 112  
Mortality rate per 1 000 py 
 
3 945 10.9 20.3 37.3  
Age (years) 3 945 56.5 (6.1) 61.1 (6.8) 66.1 (5.8) <0.001 
BMD (g/cm2) 3 945 0.472 (0.032) 0.398 (0.019) 0.316 (0.037) <0.001 
BMI (kg/m2) 3 937 26.6 (4.5) 26.2 (4.5) 25.2 (4.4) <0.001 
Grip strength (bar) 3 931 0.79 (0.20) 0.73 (0.18) 0.66 (0.18) <0.001 
Smoking 3 941    0.138 
      Never smoker, %  43.2 45.4 40.9 - 
      Current smoker, %  30.2 27.9 32.5 - 
      Previous smoker, %  26.6 26.7 26.7 - 
L-phys.act.<1 hour/week, % 3 938 25.4 26.3 29.6 0.044 
H-phys.act.<1 hour/week, % 3 903 81.9 86.0 90.4 <0.001 
Low education, % 3 915 55.2 60.8 70.2 <0.001 
 Self-reported health status 3 939    <0.001 
     Poor %    2.5   3.1   4.9 - 
     Not so good %  42.6 46.5 52.5 - 
     Good %  47.9 44.6 38.9 - 
     Very good %    7.0   5.9   3.6 - 
Stroke % 3 929   1.2   2.1   2.5 0.042 
Angina % 3 936   4.6   6.4 10.1 <0.001 
Myocardial infarction % 3 932   1.9   3.2   4.0 0.004 
Diabetes % 3 929   2.3   3.5   3.2 0.132 
Asthma % 3 927   8.0   8.9   9.0 0.577 
Men      
Number of participants 2 845 1 575 870 400  
Number of deaths 1 596 740 530 326 <0.001 
Person years (py) 2 845 26 944 13 760 5 068  
Mortality rate per 1 000 py 2 845 27.5 38.5 64.3  
Age (years) 2 845 61.2 (6.2) 63.4 (6.1) 66.8 (5.6) <0.001 
BMD (g/cm2) 2 845 0.581 (0.036) 0.501 (0.019) 0.419 (0.039) <0.001 
BMI (kg/m2) 2 843 26.6 (3.2) 25.6 (3.3) 24.9 (3.8) <0.001 
Grip strength (bar) 2 831 0.89 (0.21) 0.83 (0.20) 0.72 (0.19) <0.001 
Smoking     <0.001 
      Never smoker, % 2 844 20.9 17.5 12.8 - 
      Current smoker, % 2 844 27.4 33.0 40.8 - 
      Previous smoker, % 2 844 51.7 49.5 46.5 - 
L-phys.act.<1 hour/week, % 2 828 25.1 25.0 27.5 0.603 
H-phys.act.<1 hour/week,% 2 814 70.9 74.3 78.4 0.006 
Low education, % 2 833 47.2 45.9 52.3 0.131 
Self-reported health status 2 841    0.014 
     Poor %    3.2   2.8   6.0 - 
     Not so good %  39.8 38.4 42.7 - 
     Good %  50.9 53.4 47.7 - 
     Very good %    6.1   5.4   3.5 - 
Stroke % 2 834   2.7   3.2   6.3 0.002 
Angina % 2 836 12.2 12.2 14.3 0.515 
Myocardial infarction % 2 836   9.8 10.7 12.3 0.325 
Diabetes % 2 834   3.8   3.6   3.0 0.779 
Asthma % 2 833   7.4   6.1   9.1 0.161 
Abbreviations: L/H-phys.act. = Light/Hard physical activity, BMD = Bone Mineral Density, py = person years 
“<1 hour/week” contains both alternatives “none” and “less than one”. “ Low education” = 7 years or less. 
*Trend gives p-values based on linear regression for the continuous variables (Normal BMD coded 0, osteopenia coded 1 and 
osteoporosis coded 2) and chi square test for the categorical ones.  
 
 
Table 3. Hazard ratios (HR) with 95% confidence intervals (CI) of mortality for BMD categories: “Normal, “Osteopenia” 
and “Osteoporosis” during 22 years follow-up from 1994/1995 to November 2016. Model 1-4 progressively adjusted for age, 
lifestyle- and health related covariates.  





































        Women    Men 
Model adjusted for BMD 
category 
N HR     95% CI N HR    95% CI 
Model 1: Age Normal  1.00    1.00   
Osteopenia  1.17 1.01 1.35  1.14 1.02 1.28 
Osteoporosis  1.42 1.23 1.64  1.62 1.41 1.85 
  3 818    2 747    
Model 2: Model 1 + BMI, 
education, physical activity, 
smoking 
Normal  1.00    1.00   
Osteopenia  1.17 1.01 1.36  1.13 1.01 1.27 
Osteoporosis  1.35 1.17 1.57  1.45 1.26 1.67 
 3 818 
8183 
   2 747    
Model 3: Model 2 + self-
reported health and chronic 
diseases* 
Normal 1.00    1.00   
Osteopenia  1.18 1.02 1.36  1.14 1.01 1.28 
Osteoporosis  1.34 1.16 1.55  1.42 1.23 1.64 
 3 818    2 747    
Model 4: Model 3 + grip 
strength 
Normal  1.00    1.00   
Osteopenia  1.17 1.01 1.35  1.13 1.00 1.27 
Osteoporosis  1.32 1.14 1.53  1.37 1.19 1.58 
   3 818    2 747    
Table 4. Hazard ratios (HR) with 95% confidence intervals (CI) of mortality for BMD categories: “Normal, “Osteopenia” 
and “Osteoporosis” and after sustaining a hip fracture or osteoporotic fracture during 15 years follow-up from 1994/1995 to 
March 2010. Model 1 minimally adjusted without fractures. Model 2 and 4 minimally adjusted and model 3 and 5 fully 
adjusted for age, lifestyle- and health related covariates in addition to hip fractures (model 2 and 3) and osteoporotic 
fractures(model 4 and 5).  
*Chronic diseases include angina, asthma, stroke, myocardial infarction and diabetes. N=number of subjects included in 
analysis.  
        Women       Men 
Model adjusted for BMD 
category 
N HR     95% CI N HR    95% CI 
Model 1: Age Normal  1.00    1.00   
 Osteopenia  1.25 1.02 1.54  1.06 0.92 1.23 
 Osteoporosis  1.46 1.19 1.79  1.54 1.30 1.82 
  3 809    2 745    
 
Model 2: Model 1 + hip 
fracture 
Normal  1.00    1.00   
Osteopenia  1.24 1.01 1.53  1.05 0.90 1.21 
Osteoporosis  1.40 1.14 1.72  1.52 1.28 1.79 
  3 809    2 745    
Model 3: Model 2 + BMI, 
education, physical activity, 
smoking, self-reported 
health, grip strength and 
chronic diseases* 
Normal  1.00    1.00   
Osteopenia  1.24 1.01 1.52  1.00 0.86 1.16 
Osteoporosis  1.30 1.05 1.61  1.25 1.05 1.49 
 3 809    2 745    
 
Model 4: Age, osteoporotic 
fracture 
Normal  1.00    1.00   
Osteopenia  1.24 1.01 1.52  1.04 0.90 1.21 
Osteoporosis  1.42 1.15 1.74  1.50 1.27 1.77 
  3 809    2 745    
Model 5:  Model 4 + BMI, 
education, physical activity, 
smoking, self-reported 
health, grip strength and 
chronic diseases* 
Normal  1.00    1.00   
Osteopenia  1.23 1.00 1.51  1.00 0.86 1.17 
Osteoporosis  1.30 1.05 1.61  1.23 1.04 1.47 
  3 809    2 745    
 
Figure 1: Mortality hazard ratios with 95% confidence intervals across the range of distal forearm BMD in women with low 
grip strength (dashed curve) and in women with normal or high grip strength (solid curve). Mediating effect not significant. 
 
Figure 2: Mortality hazard ratios with 95% confidence intervals across the range of distal forearm BMD in men with low 
grip strength (dashed curve) and in women with normal or high grip strength (solid curve). Mediating effect not significant. 
